Impact of chronic hepatitis B and concurrent steatosis on the risk of hepatocellular carcinoma.

Ayada, Ibrahim; Li, Jiajing; Brouwer, Willem Pieter; de Knegt, Robert J; Pan, Qiuwei

Ayada, Ibrahim; Li, Jiajing; Brouwer, Willem Pieter; de Knegt, Robert J; Pan, Qiuwei.

Afiliação

Ayada I; Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands. i.ayada@erasmusmc.nl.
Li J; Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.
Brouwer WP; Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.
de Knegt RJ; Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.
Pan Q; Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands.

Hepatol Int ; 18(3): 1053-1055, 2024 Jun.

Article em En | MEDLINE | ID: mdl-38451406

Assuntos

Carcinoma Hepatocelular; Hepatite B Crônica; Neoplasias Hepáticas; Humanos; Carcinoma Hepatocelular/etiologia; Carcinoma Hepatocelular/epidemiologia; Neoplasias Hepáticas/etiologia; Neoplasias Hepáticas/epidemiologia; Hepatite B Crônica/complicações; Fígado Gorduroso/complicações; Fígado Gorduroso/epidemiologia; Fatores de Risco

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Hepatite B Crônica / Neoplasias Hepáticas Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google